C A Kraaijeveld
Overview
Explore the profile of C A Kraaijeveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fonseca D, van Engelen M, Kraaijeveld C, Snippe H, Verheul A
Infect Immun
. 2001 Jul;
69(8):4839-45.
PMID: 11447158
Cell-mediated immune responses are crucial in the protection against tuberculosis. In this study, we constructed DNA vaccines encoding cytotoxic T lymphocytes (CTL) and T helper cell (Th) epitopes of the...
2.
Fernandez I, Bos N, Harmsen M, Verheul A, Snippe H, Kraaijeveld C
Viral Immunol
. 2001 Jun;
14(2):119-24.
PMID: 11398807
A noninternal image monoclonal antiidiotypic antibody (ab2 mAb), designated 1.13A321, that had proved its efficacy as vaccine against infection with Semliki Forest virus (SFV) in BALB/c mice, was used as...
3.
Choy K, Wulffraat N, Wolfs T, Geelen S, Kraaijeveld C, Fleer A
Pediatr Infect Dis J
. 1999 Jun;
18(5):481-3.
PMID: 10353531
No abstract available.
4.
Fernandez I, Golding H, Benaissa-Trouw B, de Vos N, Harmsen M, Nottet H, et al.
Vaccine
. 1998 Oct;
16(20):1936-40.
PMID: 9796047
A colinearly synthesized peptide consisting of a H-2d restricted T-helper cell epitope of Semliki Forest virus (SFV) and triple repeats of sequence GPGRAF, derived from the V3 domain of HIV-1...
5.
Fernandez I, Harmsen M, Benaissa-Trouw B, Stuij I, Puyk W, Meloen R, et al.
Vaccine
. 1998 Aug;
16(16):1531-6.
PMID: 9711800
The humoral response to synthetic peptide vaccines against Semliki Forest virus (SFV) in H-2d BALB/c mice was investigated with the enzyme linked immunosorbent assay and the pepscan technique. The peptide...
6.
Benne C, Kroon F, Harmsen M, Tavares L, Kraaijeveld C, de Jong J
Clin Diagn Lab Immunol
. 1998 Feb;
5(1):114-7.
PMID: 9455891
A neutralization enzyme immunoassay (N-EIA) was used to determine the neutralizing serum antibody titers to influenza A/Taiwan/1/86 (H1N1) and Beijing/353/89 (H3N2) viruses after vaccination of 51 human immunodeficiency virus (HIV)...
7.
Benne C, Harmsen M, van der Graaff W, Verheul A, Snippe H, Kraaijeveld C
Vaccine
. 1997 Jun;
15(9):1039-44.
PMID: 9261954
The influence of various adjuvants on the development of influenza virus neutralizing antibodies and distribution of anti-influenza virus IgG isotypes after immunization of mice with influenza A (H3N2) subunit vaccine...
8.
Benne C, Van Strijp J, Kraaijeveld C, van Iwaarden J
Eur J Immunol
. 1997 Apr;
27(4):886-90.
PMID: 9130640
Surfactant protein A (SP-A) and surfactant protein D (SP-D) are collectins, and both proteins were shown to interact with influenza A virus and alveolar macrophages. However, it is not known...
9.
Benne C, Kraaijeveld C, Van Strijp J, Brouwer E, Harmsen M, Verhoef J, et al.
J Infect Dis
. 1995 Feb;
171(2):335-41.
PMID: 7844369
The interaction of pulmonary surfactant protein A (SP-A) with influenza A H1N1 and H3N2 viruses was investigated. SP-A is a sialated C type lectin with affinity for mannose residues. Flow...
10.
Benne C, Harmsen M, de Jong J, Kraaijeveld C
J Clin Microbiol
. 1994 Apr;
32(4):987-90.
PMID: 8027355
A neutralization enzyme immunoassay (N-EIA) was developed for the detection of antibody titer rises in sera of patients infected with influenza A (H3N2) virus. In this N-EIA, a selected strain...